Clinical Trial Detail

NCT ID NCT02705196
Title LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lokon Pharma AB
Indications

pancreatic ductal adenocarcinoma

Therapies

Atezolizumab + Gemcitabine + LOAd703 + Nab-paclitaxel

Gemcitabine + LOAd703 + Nab-paclitaxel

Age Groups: senior adult

No variant requirements are available.